Pricing

Start free. Prove value. Scale only after the evidence is clear.

AGX pricing follows the buying path enterprises actually need: a free read-only diagnostic, a fixed-scope paid pilot, then an annual contract only when recovered value, safety boundaries, and rollout scope are clear.

Buying path

Three steps. No vague transformation program.

Each step has a clear purpose, output, and decision point. You do not move to the next step unless the evidence supports it.

Step 1

Free diagnostic

A 1-2 week read-only review. AGX frames one revenue or margin problem, checks whether the evidence is usable, estimates the value at stake, and names the evidence gaps. Output: a leakage report and next-step recommendation.

Step 3

Annual contract

Continuous revenue intelligence for approved workflows. AGX monitors evidence, prepares recovery actions, tracks outcomes, adapts when conditions change, and keeps owner approval and audit boundaries intact.

Pricing principle Pricing follows validated value, not feature checklists.

The diagnostic estimates the opportunity. The pilot tests whether recovery actions would have worked. The annual contract scales only where the value, cohort, owner boundary, and evidence quality are explicit.

Pricing model

Clear commercial stages.

Use the diagnostic to decide whether a pilot is worth funding. Use the pilot to decide whether an annual contract is justified.

Free diagnostic

$0

A no-cost, read-only diagnostic that quantifies the likely leakage and tells you whether the evidence can support a paid pilot.

Start diagnostic
  • 1-2 week time-boxed review
  • One revenue, margin, cash, cost, or control problem
  • Leakage estimate and root-cause hypotheses
  • Evidence gaps named explicitly
  • Output: leakage report and recommended next step

Annual contract

$60k-$250k+ / year

Ongoing revenue intelligence for approved workflows, with pricing tied to scale and validated economic value.

Discuss annual scope
  • Everything in Paid pilot
  • Base subscription by workflow scale, systems, and evidence volume
  • Optional value component tied to validated recovered revenue or margin
  • Continuous monitoring, revalidation, and evidence feedback
  • Owner approval, rollback, and policy boundaries preserved

The diagnostic is free because its job is qualification: find the likely value, evidence quality, and whether a paid pilot is worth doing.

The paid pilot is fixed-scope and read-only. It does not change production systems, approve actions, or bypass owners.

Annual pricing is value-based but predictable: a base subscription, with optional capped upside tied to validated recovery or managed workflow scale.

FAQ

Pricing questions teams ask first.

The commercial path is designed to reduce buyer risk: diagnose for free, prove impact in a paid pilot, then scale only where the economics are clear.

What happens in the free diagnostic?
AGX frames one business problem, reviews read-only evidence, estimates the leakage or margin opportunity, identifies likely root causes, and tells you whether a paid pilot is justified.
Why pay for the pilot?
The pilot is where AGX tests recovery actions against historical cases, measures value, checks policy adherence, and produces the evidence package needed to justify an annual contract.
What determines whether the pilot is $15k or $50k?
Scope. A narrower billing-readiness pilot sits toward the lower end. Multi-system evidence, deeper integration, human-in-loop workflow testing, full replay, and shadow-mode validation move it toward the higher end.
How is the annual contract priced?
Annual contracts usually combine a base subscription with scale or value alignment. The base is typically tied to workflow scope, systems, evidence volume, and operating complexity. Some contracts include a capped component tied to validated recovered revenue or margin.
Does the diagnostic or pilot change production systems?
No. The diagnostic and pilot are read-only. They use historical evidence, controlled views, Snowflake BYOC, or approved exports. No live writes, no approval bypass, and no production action.
What counts as success in the pilot?
Clear economic lift plus preserved controls. Typical measures include recovered value, loss reduction, reduced manual rework, time saved, policy adherence, zero unauthorized actions, and evidence quality.
What if the pilot does not prove value?
Then AGX reports what failed: weak evidence, unsupported causal claim, insufficient value, or unsafe control boundary. That is a useful outcome because it prevents a bad rollout.

Start with the free diagnostic.

Bring one revenue, margin, cash, cost, or control problem. AGX will tell you whether the evidence supports a paid pilot and what value is worth testing.

Start diagnostic → Free diagnostic · Fixed-scope pilot · Annual contract only after evidence